Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models
NCT07005414
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Autism Spectrum Disorder
Interventions
DRUG:
Bumetanide
BEHAVIORAL:
Treatment as usual (TAU)
Sponsor
Fei Li